Viatar CTC Solutions Announces the Appointment of Four

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Viatar CTC Solutions Announces the Appointment of Four Directors to the Board of Directors

LOWELL, MA--(Marketwired - May 23, 2016) - Viatar CTC Solutions Inc. (OTCQB: VRTT) a medical technology company focused on the treatment of patients with metastatic cancer, today announced the appointment of four senior business executives to the Company's Board of Directors. The appointments of David Boral, Thomas Gallo and Dr. David Tierney are effective immediately. Jack Stover will join Viatar's board on July 1, 2016. All are newly created positions that will join Ilan Reich, Viatar's founder, Chairman and CEO, on Viatar's board.

David Boral (33) has over 10 years of capital markets and investment banking experience. He is the Managing Director, Business Development of Aeon Fund, a family of investment vehicles designed and operated to provide access to primary and secondary alternative investment products. He joined the firm in February 2016. Previously, Mr. Boral served as Vice President of Fantex Holdings, a venture capital backed investment bank and market place from December 2014 to April 2015. From December 2011 to June 2014 he served as the Vice President of Costal Equities/John Carris Investments, a boutique brokerage firm. Mr. Boral holds Series 7, 24, 63, 66 and 79 licenses.

Thomas Gallo (53) is a senior investment banker with extensive experience in securities and finance. He founded Strategic Advisory Group @ Corinthian Partners ("SAG"), a boutique investment bank, and served as SAG's Senior Managing Director from February 2014 to June 2015. In June 2015, Mr. Gallo shifted SAG to Newbridge Securities ("NBS"), a full service investment bank and broker dealer. Since June 2015 he has served as the Senior Managing Director at SAG at NBS. Prior to his tenure at SAG, Mr. Gallo worked at Garden State Securities as an Investment Advisor to high net worth investors and as Strategic Advisor and Investment Banker to public companies, a position he held from January 2010 to February 2014. In 2003 Mr. Gallo co-founded and was the Managing Director of Moneta Capital Advisors, and from 2001 until 2003 he was President of Kirlin Securities. From 1991 to 2001 Mr. Gallo was a founding member, President, Chief Executive Officer and Chairman of the board of M.S. Farrell & Co, Inc., an investment banking firm which was acquired by Kirlin Securities. From 1985 to 1991 Mr. Gallo held sales and trading positions at a number of financial institutions including Lehman Brothers and Bear Stearns & Co.

Jack Stover (63) has served as the interim President, Chief Executive Officer and a member of the board of directors of Interpace Diagnostics Group Inc. since December 2015. Since September 2013, Mr. Stover has also served as the Chief Executive Officer of Zebec Therapeutics LLC. Since May 2016, Mr. Stover has served as a member of the board of directors and chairman of the audit committee of Onconova Therapeutics Inc., and since June 2015 he has served as a member of the board of directors of Cernostics, Inc. From 2005 to 2015 Mr. Stover served as a member of the board of directors and chairman of the audit committee of PDI Inc., and from 2008 to 2015 he was engaged by JEStoverConsulting LLC. From March 2004 to October 2008 Mr. Stover was the Chief Executive Officer and a member of the board of directors of Antares Pharma Inc.

David Tierney, MD, (53) is a well-respected leader in the Life Sciences sector. He has served as the Chief Executive Officer of Icon Bioscience, Inc., a privately-held ophthalmic drug delivery company since March 2014. From February 2013 to March 2014 he was a Venture Partner at Signet Healthcare Partners. Dr. Tierney co-founded Oceana Therapeutics, Inc. ("Oceana") and from June 2008 to December 2011 he served as the President, Chief Operating Officer and a member of the board of Oceana until the Company was acquired by Salix Pharmaceuticals, Ltd. From August 2000 to April 2007 Dr. Tierney served as the President, Chief Executive Officer and a member of the board of Valera Pharmaceuticals, Inc. ("Valera") until Valera was acquired by Indevus Pharmaceuticals, Inc., and from January 2000 to August 2000 he served as the President of Biovail Technologies. From March 1997 to January 2000 Dr. Tierney served as the Senior Vice President of Drug Development at Roberts Pharmaceutical Corporation, and from January 1990 to April 1997 he served as the Medical Director of Elan Pharmaceuticals. Dr. Tierney has been serving as a member of the board of KemPharm, Inc. since March 2014 and a member of the board of Catalyst Pharmaceuticals since April 2002. Dr. Tierney received his medical degree from the Royal College of Surgeons in Dublin, Ireland and was subsequently trained in internal medicine.

About Viatar CTC Solutions

Viatar CTC Solutions Inc., the cancer dialysis company, is a medical technology company focused on the treatment of patients with metastatic cancer. The company's lead product, the Viatar® Therapeutic Oncopheresis System, removes circulating tumor cells from whole blood using label-free cross-flow filtration. Pending regulatory approval targeted for 2017, it will be used as a periodic therapy to improve overall survival for a wide range of solid tumor types such as lung, breast, colon, prostate and gastric cancers. This proprietary technology also powers the company's liquid biopsy products, which are collection systems for use by genetic testing companies, researchers and medical oncologists that provide a greater quantity and purity of circulating tumor cells for their molecular analysis and personalized medicine objectives.

Forward Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in the Company's filings with the SEC.

For More Information: For Viatar CTC Solutions: Ilan Reich Chairman & CEO ilan.reich@viatarctcsolutions.com Investor Contact: Stephanie Prince PCG Advisory Group 646.762.4518 Sprince@pcgadvisory.com Media Contact: Sean Leous PCG Advisory Group 646.863.8998 Sleous@pcgadvisory.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AR Cards in Casino Gaming: A High-Stakes Revolution

Updated Category News Views 13

A New Breed of Casino Experience Walk into a casino today, and you might just enter a whole new reality. No, this isn’t a cheesy magician’s trick or a glitzy PR stunt—this is the real deal brought to you by augmented reality (AR) trading cards. Imagine the slots you love wrapped in a sci-fi movie where characters leap out, tap you on the shoulder, and call you by...

Continue Reading
Nevada Expands Rural Youth Mental Health Access

Updated Category News Views 148

Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 221

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 199

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 39

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Exploring Creation: A Fresh Look at Genesis

Updated Category News Views 67

Opening Up Genesis in a New Light Hey, if you’re like most folks, you’ve probably heard Genesis framed as the battleground for science versus religion debates, right? Enter into this mix a fresh take with Robert E. Franzen’s new book, The Narration of Creation. This book asks you to overlook those grand philosophical fights and instead focus on the narrative itself....

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 278

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 106

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 53

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
Trades Workforce Shortage Costs Wallop U.S. Economy

Updated Category News Views 83

The Forgotten Backbone of America Don't sleep on this: America's got itself a trade worker crisis, and it's not just a numerical hiccup. We’re down nearly 1.9 million skilled trades workers, and that's a gut punch to the economy—a hefty $1.2 billion a day in GDP loss. These are the folks who keep the wheels greased, the lights on, and the goods flowing. Without them,...

Continue Reading

Top 5 Most Recently Viewed Articles

boberdoo Launches Dynamic Consent for Enhanced User Privacy

Updated Category News Views 92

boberdoo's Innovative Approach to One-to-One Consent boberdoo is making waves with its Dynamic Consent solution, a vital tool for businesses looking to comply with the FCC's one-to-one consent regulation. This live solution has been available since May 2024 and is designed to enhance transparency in lead generation by allowing consumers to have a voice in which companies...

Continue Reading
Understanding the Recent Private Student Loan Trends and Insights

Updated Category News Views 254

Overview of Recent Trends in Private Student Loans In the recent semi-annual Private Student Loan Report released by Enterval Analytics, insights into the current status of private student loans reveal a stable repayment landscape. Since Enterval focuses on the private student loan market, their findings shed light on how borrowers are adapting their financial strategies...

Continue Reading
Kyocera Unveils Exclusive Knife Set Celebrating 40 Years of Innovation

Updated Category News Views 62

Kyocera celebrated four decades of pushing boundaries in ceramic cutlery, revealing an exclusive two-piece knife set designed for both chefs and home cooks. The knives—a 4.5-inch Utility and a 5.5-inch Santoku—come dressed in vibrant Aegean Blue or Botanical Green and carry a price tag of $85. This limited-edition release is set to hit select retailers by late fall...

Continue Reading
PTC Plans Conference Call for Upcoming Fiscal Q1 Results

Updated Category News Views 145

PTC to Hold Fiscal Q1 Conference Call Boston, January 2026 — PTC (NASDAQ: PTC) is gearing up to unveil its financial performance for the first quarter of fiscal year 2026 on February 4. Investors and interested parties are invited to join a conference call and webcast at 5 PM Eastern Time, right after the stock market closes. This event will provide valuable insights...

Continue Reading
Moke America Unveils Enhanced Electric Street Vehicle for All

Updated Category News Views 282

Introducing the New Electric Street-Legal Moke Moke America, the beloved electric vehicle manufacturer, has taken a bold step forward with the launch of its latest street-legal Moke. Previously classified as a Low Speed Vehicle, this newly upgraded Moke can now reach an impressive top speed of 45 MPH, transforming the driving experience into something truly exhilarating....

Continue Reading